NEW YORK – OpGen announced on Tuesday that it has inked a definitive agreement with a US-based investor for a $25 million registered direct offering.
The unnamed healthcare-focused institutional investor is purchasing 2,784,184 shares of common stock and 5,549,149 prefunded warrants where each warrant is exercisable for one share of common stock, OpGen said. In a concurrent private placement, the company is issuing unregistered common share purchase warrants to purchase 4,166,666 shares of common stock.